Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)

Le Tourneau, C.Rischin, D.Groenland, S.Lim, A.Martin-Liberal, J.Moreno, V.Trigo, J. M.Mathew, M.Cho, D.Hansen, A.Baz, D. VincenteMaio, M.Italiano, A.Bauman, J.Chisamore, M.Zhou, H.Ellis, C.Ballas, M.Hoos, A.Angevin, E.2025-01-072025-01-072020-03-010923-7534https://hdl.handle.net/10668/27107enInducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)conference outputopen access10.1016/j.annonc.2020.01.0491569-8041http://www.annalsofoncology.org/article/S0923753420359822/pdf521074400002